HER2 positive breast cancer treatment, past and future
HER2 positive breast cancer treatment, past and future
Preventing metastases by tackling exosomes
Where next for chronic lymphocytic leukaemia in the elderly?
Moving breast cancer stem cell therapies to the clinic
A new trial alters therapy landscape in multiple myeloma
Breast cancer psychosocial and survivorship issues: are we doing better?
Male breast cancer: Opportunities for increased research funding and clinical trial access
PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy
Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy
Where to next for the elderly with acute myeloid leukaemia?
Exciting new developments in the treatment of multicentric Castleman disease
Adjuvant bisphosphonate therapy in breast cancer